Viewing Study NCT05487495


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2025-12-30 @ 12:20 AM
Study NCT ID: NCT05487495
Status: WITHDRAWN
Last Update Posted: 2024-11-14
First Post: 2022-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/Lymphoma
Sponsor: Beijing Boren Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module